Table 2 Clinical outcomes, demographics and clinical features on admission

N/Total (%)

225/391 (57)

124/391 (32)

42/391 (11)

Gender (M:F)

139:86

64:60

34:8

P = 0.003

Age (years)

24 (20–34)*^$

22 (18–33)*^$

45 (37–54)^$#

^$#P < 0.001; *P > 0.05

TTP (hours)

4.6 (2.7–-7.1)

5.3 (3.4–8.8)

4.5 (3.4–5.8)

P = 0.1431

GCS

15 (15-15)*^$

15 (12–15)*^$

7 (3–13)^$#

^$# *P < 0.0001

MABP (mmHg)

89 (82–97)^$#

83 (76–90)*^$

78 (72–86)*^#

^$#P < 0.001; *P > 0.05

TTD (days)

2.2 (1.7–3.1)*

3.3 (2.6–5.0)*

1.5 (1.1–2.4)

*P < 0.001

Admission propanil concentration (μM)

1.3 (0.0–7.7)^$*

(n = 125)

8.9 (2.8–35.2)^#*

(n = 67)

72.0(45.8–128.3)^#$

(n = 19)

*^$#P < 0.001